- Home
- IDYA vs HBI Comparison
IDYA vs HBI Comparison
Compare IDYA & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- HBI
- Stock Information
- Founded
- IDYA 2015
- HBI 1901
- Country
- IDYA United States
- HBI United States
- Employees
- IDYA N/A
- HBI N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- IDYA Health Care
- HBI Consumer Discretionary
- Exchange
- IDYA Nasdaq
- HBI Nasdaq
- Market Cap
- IDYA 2.6B
- HBI 3.1B
- IPO Year
- IDYA 2019
- HBI 2006
- Fundamental
- Price
- IDYA $26.91
- HBI $8.30
- Analyst Decision
- IDYA Strong Buy
- HBI Hold
- Analyst Count
- IDYA 12
- HBI 5
- Target Price
- IDYA $53.67
- HBI $6.90
- AVG Volume (30 Days)
- IDYA 997.6K
- HBI 5.5M
- Earning Date
- IDYA 11-04-2024
- HBI 02-13-2025
- Dividend Yield
- IDYA N/A
- HBI N/A
- EPS Growth
- IDYA N/A
- HBI N/A
- EPS
- IDYA N/A
- HBI N/A
- Revenue
- IDYA $3,922,000.00
- HBI $5,466,904,000.00
- Revenue This Year
- IDYA N/A
- HBI N/A
- Revenue Next Year
- IDYA $251.89
- HBI $1.40
- P/E Ratio
- IDYA N/A
- HBI N/A
- Revenue Growth
- IDYA N/A
- HBI 25.57
- 52 Week Low
- IDYA $24.72
- HBI $3.88
- 52 Week High
- IDYA $47.74
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- IDYA 45.25
- HBI 55.87
- Support Level
- IDYA $24.72
- HBI $8.26
- Resistance Level
- IDYA $26.86
- HBI $8.81
- Average True Range (ATR)
- IDYA 1.23
- HBI 0.28
- MACD
- IDYA 0.04
- HBI -0.06
- Stochastic Oscillator
- IDYA 46.89
- HBI 45.51
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces more than 70% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.